Literature DB >> 3917348

Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.

R Beasley, D A Smith, D J McHaffie.   

Abstract

Heart rate at rest and during increasing workloads was measured in a double blind study of 12 patients with chronic atrial fibrillation when serum concentrations of digoxin were nil and at low and high therapeutic values. Twelve normal subjects were studied for comparison. The heart rate at all levels of exercise in most patients with atrial fibrillation was not adequately controlled by any serum digoxin concentration tested despite a reduction in heart rate with increasing serum digoxin concentrations. Control of the resting heart rate, even in patients with high serum digoxin concentrations, did not ensure adequate control of the heart rate during work rates equivalent to regular daily activities.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917348      PMCID: PMC1415415          DOI: 10.1136/bmj.290.6461.9

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  10 in total

Review 1.  The use of digitalis glycosides in sinus rhythm.

Authors:  A Guz; D McHaffie
Journal:  Clin Sci Mol Med       Date:  1978-11

Review 2.  Human cardiovascular adjustments to exercise and thermal stress.

Authors:  L B Rowell
Journal:  Physiol Rev       Date:  1974-01       Impact factor: 37.312

3.  An equation for prediction of energy expenditure of walking and running.

Authors:  W H van der Walt; C H Wyndham
Journal:  J Appl Physiol       Date:  1973-05       Impact factor: 3.531

4.  Digoxin dosage and ventricular rate at rest and exercise in patients with atrial fibrillation.

Authors:  A Redfors
Journal:  Acta Med Scand       Date:  1971-10

5.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

6.  Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation.

Authors:  J Yahalom; H O Klein; E Kaplinsky
Journal:  Chest       Date:  1977-05       Impact factor: 9.410

7.  The time course during 36 weeks' endurance training of changes in Vo2 max. and anaerobic threshold as determined with a new computerized method.

Authors:  D A Smith; T V O'Donnell
Journal:  Clin Sci (Lond)       Date:  1984-08       Impact factor: 6.124

8.  Digitalis.

Authors:  D N Sharpe
Journal:  N Z Med J       Date:  1983-04-27

9.  The beneficial effects of verapamil in chronic atrial fibrillation.

Authors:  H O Klein; H Pauzner; E Di Segni; D David; E Kaplinsky
Journal:  Arch Intern Med       Date:  1979-07

10.  Evidence of vagal neuropathy in chronic alcoholics.

Authors:  G Duncan; R H Johnson; D G Lambie; E A Whiteside
Journal:  Lancet       Date:  1980-11-15       Impact factor: 79.321

  10 in total
  20 in total

Review 1.  Pharmacological control of rate and maintenance of sinus rhythm.

Authors:  M D Ezekowitz; R Lampert
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 2.  Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins.

Authors:  F De Rienzo; R R Gabdoulline; R C Wade; M Sola; M C Menziani
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

3.  Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation.

Authors:  H E Bøtker; P Toft; N A Klitgaard; E E Simonsen
Journal:  Br Heart J       Date:  1991-06

Review 4.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 5.  Rate control in the medical management of atrial fibrillation.

Authors:  A J Camm; I Savelieva; G Y H Lip
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

Review 6.  Atrial fibrillation. The therapeutic options.

Authors:  R V Lewis
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

7.  The value of therapeutic drug monitoring to the practising physician--an hypothesis in need of testing.

Authors:  G T McInnes
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

Review 8.  Atrial fibrillation: how to approach rate control.

Authors:  Lynda E Rosenfeld
Journal:  Curr Cardiol Rep       Date:  2005-09       Impact factor: 2.931

Review 9.  Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.

Authors:  Giuseppe Boriani; Mauro Biffi; Igor Diemberger; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.

Authors:  J M Rawles; M J Metcalfe; K Jennings
Journal:  Br Heart J       Date:  1990-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.